Linn Hofsøy Steffensen
Dimitrios Kleftogiannis,
Sonia Gavasso,
Live Egeland Eidem,
Jonas Bull Haugsøen,
Trygve Holmøy,
Linn Hofsøy Steffensen
m.fl.:
Intrathecal mesenchymal stem cell therapy in progressive multiple sclerosis: integrated blood and CSF profiling in the SMART-MS randomized trial
Øivind Torkildsen,
Hilde Kjelgaard Brustad,
Einar August Høgestøl,
Karl Bjørnar Alstadhaug,
Alok Bhan,
Heidi Øyen Flemmen
m.fl.:
Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis
Christopher Elnan Kvistad,
Torbjørn Kråkenes,
Trygve Holmøy,
Live Egeland Eidem,
Linn Hofsøy Steffensen,
Kristin Wesnes
m.fl.:
Intrathecal Mesenchymal Stem Cells in Progressive Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial (SMART-MS)
Susanne Ingebrigtsen,
Linn Hofsøy Steffensen,
Kurt Bøckman Gschib,
Øyvind Solbakken,
Tor Ingebrigtsen,
Ellisiv Bøgeberg Mathiesen
m.fl.:
Prehospital thrombolytic treatment of acute ischemic stroke using a remotely controlled CT scanner
Kristin Busund,
Linn Hofsøy Steffensen,
Amalie Hauan,
Ellisiv B. Mathiesen,
Agnethe Eltoft
:
Geografiske forskjeller i trombolysebehandling ved akutt hjerneinfarkt
Barbara Ratajczak-Tretel,
Anna Tancin Lambert,
Riadh Ibrahim Mahmud Al-Ani,
Kathrine Grønning Arntzen,
Grete Bakkejord,
Hanna Marie Otterholt Bekkeseth
m.fl.:
Prediction of underlying atrial fibrillation in patients with a cryptogenic stroke: results from the NOR-FIB Study
Anna Tancin Lambert,
Barbara Ratajczak-Tretel,
Riadh Ibrahim Mahmud Al-Ani,
Kathrine Grønning Arntzen,
Grete Bakkejord,
Hanna Marie Otterholt Bekkeseth
m.fl.:
Biomarkers predictive of atrial fibrillation in patients with cryptogenic stroke. Insights from the Nordic Atrial Fibrillation and Stroke (NOR-FIB) study
Barbara Ratajczak-Tretel,
Anna Tancin Lambert,
Riadh Ibrahim Mahmud Al-Ani,
Hanna Marie Otterholt Bekkeseth,
Grete Bakkejord,
Vigdis Bjerkeli
m.fl.:
Underlying causes of cryptogenic stroke and TIA in the nordic atrial fibrillation and stroke (NOR-FIB) study – the importance of comprehensive clinical evaluation
Barbara Ratajczak-Tretel,
Anna Tancin Lambert,
Riadh Ibrahim Mahmud Al-Ani,
Kathrine Grønning Arntzen,
Grete Bakkejord,
Hanna Marie Otterholt Bekkeseth
m.fl.:
Atrial fibrillation in cryptogenic stroke and TIA patients in The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Main results
Øivind Fredvik Torkildsen,
Kjell-Morten Myhr,
Vegard Skogen,
Linn Hofsøy Steffensen,
Kjetil Lauvland Bjørnevik
:
Tenofovir as a treatment option for multiple sclerosis
Barbara Ratajczak-Tretel,
Anna Tancin Lambert,
Henriette Johansen,
Bente Halvorsen,
Vigdis Bjerkeli,
David Russell
m.fl.:
Atrial fibrillation in cryptogenic stroke and transient ischaemic attack – The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Rationale and design
Trygve Holmøy,
Egil Rørvik Røsjø,
Henrik Zetterberg,
Kaj Blennow,
Jonas Christoffer Lindstrøm,
Linn Hofsøy Steffensen
m.fl.:
Vitamin D supplementation and neurofilament light chain in multiple sclerosis
Egil Rørvik Røsjø,
Peter Andreas Vold Lossius,
Nada Abdelmagid,
Jonas Christoffer Lindstrøm,
Margitta Theodora Kampman,
Lone Jørgensen
m.fl.:
Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein-Barr virus in relapsing-remitting multiple sclerosis
Trygve Holmøy,
Jonas Christoffer Lindstrøm,
Erik Fink Eriksen,
Linn Hofsøy Steffensen,
Margitta Theodora Kampman
:
High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis - a randomized controlled trial
Egil Rørvik Røsjø,
Linn Hofsøy Steffensen,
Lone Jørgensen,
Jonas Christoffer Lindstrøm,
Jurate Saltyte Benth,
Annika Michelsen
m.fl.:
Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis
Linn Hofsøy Steffensen,
Magritt Brustad,
Margitta Theodora Kampman
:
What is needed to keep persons with multiple sclerosis vitamin D-sufficient throughout the year?
Margitta Theodora Kampman,
Linn Hofsøy Steffensen,
Svein Ivar Mellgren,
Lone Jørgensen
:
Effect of vitamin D-3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial
Linn Hofsøy Steffensen,
Lone Jørgensen,
Bjørn Straume,
Svein Ivar Mellgren,
Margitta Theodora Kampman
:
Can vitamin D-3 supplementation prevent bone loss in persons with MS? A placebo-controlled trial
Margitta Theodora Kampman,
Linn Hofsøy Steffensen
:
The role of vitamin D in multiple sclerosis
Linn Hofsøy Steffensen,
Svein Ivar Mellgren,
Margitta Theodora Kampman
:
Predictors and prevalence of low bone mineral density in fully ambulatory persons with multiple sclerosis
Linn Hofsøy Steffensen,
Svein Ivar Mellgren,
Margitta Theodora Kampman
:
Predictors and prevalence of low bone mineral density in fully ambulatory persons with multiple sclerosis
Bakke, Magnus Ellingsen Jentoft,
Linn Hofsøy Steffensen
:
Hvordan er kvaliteten på monitoreringen av multippel sklerose (MS) ved UNN Tromsø, målt gjennom EDSS-skåring, MR-undersøkelser og attakkregistrering, og hvilke faktorer oppleves som barrierer eller suksessfaktorer for optimal oppfølging ifølge helsepersonell
UiT Norges arktiske universitet 29. mai 2026 ARKIV
Egil Rørvik Røsjø,
Andreass Lossius,
Nada Abelmagid,
Jonas Christoffer Lindstrøm,
Margitta Theodora Kampman,
Lone Jørgensen
m.fl.:
Selective and transient effect of vitamin D3 supplementation on antibody responses against Epstein-Barr virus nuclear antigen 1 in relapsing-remitting multiple sclerosis
2017 ARKIV
Egil Rørvik Røsjø,
Kjell-Morten Myhr,
Margitta Theodora Kampman,
Kristin Ingeleiv Løken-Amsrud,
Linn Hofsøy Steffensen,
Søren Jacob Bakke
m.fl.:
Vitamin D og interferon-behandling ved multippel sklerose
2015 ARKIV
Linn Hofsøy Steffensen,
Magritt Brustad,
Guri Skeie,
Leif Jørgensen,
Yngve Figenschau,
Margitta Theodora Kampman
:
Vitamin D status in individuals with multiple sclerosis at baseline and after supplementation with 20,000 IU cholecalciferol a week for 48 weeks
Multiple Sclerosis 2009 ARKIV
De 50 siste resultatene vises på siden. Se alle arbeider i NVA her →